Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS -8.06%·Rev n/aQ1 23EPS -16.95%·Rev n/aQ4 22EPS -19.83%·Rev n/aQ3 22EPS -9.40%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Senior Vice President of Corporate Communications and Investor Relations

Robert Blum — President and Chief Executive Officer

Fady Malik — Executive Vice President of Research and Development

Steve Heitner — Executive / Clinical Development (inferred)

Andrew Callos — Commercial Readiness Team Lead (inferred) / Executive

Robert Wong — Chief Financial Officer

Ching Jaw — Executive / Strategic Planning (inferred)

Unidentified Analyst

Robert Blum –

+4.7%1d on move date+5.2% vs SPY3d+0.8%5d+2.5%

Research tier

Behavioral profile computed for 9 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access